Vyleesi Injection
Product Images NDC 80064-141

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Vyleesi (NDC 80064-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Palatin Technologies, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vyl00 0002 01

FDA Label Image

Vyl00 0002 02

FDA Label Image

Vyl00 0002 03

FDA Label Image

Vyl00 0002 04

This is a set of instructions for a medication known as Vyleesi (bremelanotide). It comes in a 175 mg/0.3 mL dose and is administered via subcutaneous injection.*

FDA Label Image

Vyl00 0002 05

This appears to be a description of different parts of an autoinjector device, potentially for the medication Vyleesi. It includes information about an expiration date and various components such as a view window, clear cap, gray tip, and purple window/tip. The text may be incomplete or contain errors (e.g. "thereis" instead of "there is" and incomplete sentences), but it is possible to gather a basic understanding of the product from the provided information.*

FDA Label Image

Vyl00 0002 06

Vyleesi is a medication name (pronounced vahy-lee-see). No further information is provided.*

FDA Label Image

Vyl00 0002 07

FDA Label Image

Vyl00 0002 08

FDA Label Image

Vyl00 0002 09

FDA Label Image

Vyl00 0002 10

FDA Label Image

Vyl00 0002 11

FDA Label Image

Vyl00 0002 12

FDA Label Image

Vyl00 0002 13

FDA Label Image

Vyl00 0002 14

FDA Label Image

Vyl00 0002 15

The text seems to be a part of some guide or instruction manual that explains the sixth step of a procedure. The step instructs the user to dispose of an autoinjector in a way that is inaccessible to children. The rest of the text may not be readable due to errors.*

FDA Label Image

Vyl00 0002 16

FDA Label Image

Vyl00 0002 17

FDA Label Image

Vyl00 0002 18

FDA Label Image

Vyl00 0002 19

This is a product description for Vyleesi, a medication with bremelanotide injection used for subcutaneous use. This is a single-dose autoinjector and should not be taken more than 1 dose within 24 hours or eight doses per month. It is manufactured by Palatin Technologies, Inc. and comes with an NDC of 80064 141 01. Users are advised to store it at or below the temperature of 25°C (77°F), not freeze, and keep it away from light. NERI® is also mentioned, but it is unclear how it relates to Vyleesi.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.